[Beclomethasone dipropionate, budesonide and flunisolide in the treatment of bronchial asthma (a review of the literature and the authors' own research)].
I M Kakhnovskiĭ, A S Solomatin
Index: Ter. Arkh. 67(3) , 34-8, (1995)
Full Text: HTML
Abstract
Inhalation corticosteroids (beclometasone dipropionate, budesonide, flunisolide) proved effective against bronchial asthma (BA) and safe as they induce no severe systemic side effects. Of these three drugs side effects arise most frequently in administration of beclometasone dipropionate, least frequently of flunisolide. These inhalation corticosteroids are indicated both in non-steroid-dependent and steroid-dependent BA to reduce the dose of oral steroids or, if possible, for their complete discontinuation. Flunisolide is the most potent and effective of all inhalation corticosteroids used in current practice.
Related Compounds
Related Articles:
2014-08-30
[Rapid Commun. Mass Spectrom. 28(16) , 1829-39, (2015)]
Intranasal flunisolide treatment in patients with non-allergic rhinitis.
2011-01-01
[Int. J. Immunopathol. Pharmacol. 24(2) , 401-9, (2011)]
Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
2003-03-01
[Clin. Ther. 25(3) , 776-98, (2003)]
2009-01-01
[Int. J. Immunopathol. Pharmacol. 22(2) , 363-70, (2009)]
Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
2012-01-01
[Cochrane Database Syst. Rev. 4 , CD002311, (2012)]